TABLE 1.
Summary of pretreatment status and rate of loss of productively infected CD4+ T cells in nine study subjects
| Patient | Pretreatment
|
Rate of loss of productively infected CD4+ T cells
|
||||
|---|---|---|---|---|---|---|
| HIV-1 RNA Log no. of copies/ml of plasma | No. of CD4 cells/mm3 | δ (day−1) | t1/2 (days) | 95% Confidence limit
|
||
| Lower | Upper | |||||
| 202 | 4.7 | 224 | 0.6 | 1.1 | 0.5 | 1.9 |
| 204 | 4.4 | 365 | 1.2 | 0.6 | 1.0 | 1.5 |
| 205 | 5.9 | 167 | 1.4 | 0.5 | 0.9 | 1.9 |
| 206 | 5.8 | 339 | 1.3 | 0.5 | 0.7 | 2.8 |
| 207 | 4.6 | 289 | 1.3 | 0.6 | 0.8 | 2.4 |
| 209 | 4.6 | 280 | 0.8 | 0.9 | 0.6 | 1.7 |
| 210 | 5.2 | 372 | 0.9 | 0.8 | 0.6 | 1.6 |
| 211 | 4.5 | 377 | 1.0 | 0.7 | 0.7 | 1.6 |
| 212 | 4.3 | 700 | 0.9 | 0.8 | 0.6 | 1.3 |
| Mean ± SD | 4.9 ± 0.6 | 346 ± 151 | 1.0 ± 0.3 | 0.7 ± 0.2 | ||